Glutakem Solution for Infusion contains L-alanyl-L-glutamine (20 gm), a dipeptide composed of alanine and glutamine, designed to provide a stable and highly soluble source of glutamine for parenteral nutrition. Glutamine is a conditionally essential amino acid critical for various metabolic processes, including nitrogen transport, immune function, and intestinal mucosal integrity. In clinical settings, glutamine supplementation is particularly beneficial for patients undergoing major surgery, trauma, burns, or critical illness, where endogenous glutamine levels are depleted, impairing recovery and increasing susceptibility to infections. Glutakem Solution for Infusion is administered intravenously as part of total parenteral nutrition (TPN) or supplemental nutrition regimens to support nitrogen balance, enhance protein synthesis, and promote tissue repair. The dipeptide form offers improved stability and solubility compared to free glutamine, reducing degradation during storage and infusion. The solution should be used under strict aseptic conditions, with dosing individualized based on patient weight, clinical condition, and nutritional requirements. It is contraindicated in patients with known hypersensitivity to any component and should be used cautiously in those with hepatic or renal impairment. Monitoring of metabolic parameters is recommended during therapy to ensure safety and efficacy. Glutakem contributes to improved clinical outcomes by addressing glutamine deficiency in critically ill patients.